Interpretive Guidelines


This page contains links to important information and resources focusing on topics related to substance use disorders, opioid use disorders and harm reduction. Some are historical documents  from Smart Alerts and emails in previous fiscal years that include important information (e.g., standards, updates) for reference.

If you have questions about any information shared on this page, please direct them to SUPR's help desk at

Revised Administrative Rule 2060 Open Public Comment

The above Smart Alert from Laura Garcia, Director of the Illinois Department of Human Services, Division of Substance Use Prevention and Recovery (IDHS/SUPR) addresses the formal adoption process of a revised new rule that will replace the current Part 2060. The title of the new rule will still be Part 2060 and the process and timeframe for submitting comments or feedback is identified in the Smart Alert.

Please give the Smart Alert your immediate attention and share with all organization staff, as appropriate.

\Xylazine/Tranq March 2023 (pdf)

Naloxone Bulletin 2.14.23

Tuberculosis Testing Regulations and TB Patient Education Billing Requirements

IDHS SUPR Expired Naloxone Guidance (pdf)

Guideline- Methadone in Pregnancy (pdf)

Harm Reduction for Opioid Use Disorder (pdf)

Medication-Assisted Recovery (MAR) (pdf)

Recovery Homes and MAR (pdf)

Illinois ROSC Principals (pdf)

Telemedicine and Prescribing Buprenorphine for the Treatment of Opioid Use Disorder (pdf)

Use of Telemedicine While Providing Medication Assisted Treatment (MAT) (pdf)

Use of MAR with Youth (pdf)

Guidelines for Counselors Assisting Illinois "Voluntary Self-Exclusion Program for Problem Gamblers" Enrollees Seeking Removal from the SEP List (pdf)

Methadone Dosage Sharing Brochure 9-12-22 (pdf)


DSM-5 Implementation

New Name for DASA

Physician Extenders

Supportive Services Enhancement & Revised Billing Procedures

The ASAM Criteria & DSM 5